Skip to Main Content

Paper Details

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
Ann Intern Med
36
2023
CKD, Chronic Kidney Disease, Diabetes, Glucose, Kidney Disease, Patients, T2D, cardiovascular, chronic kidney disease, diabetes, glucagon-like peptide-1 receptor, glucose, mineralocorticoid receptor, patients, sodium, sodium-glucose cotransporter-2
Author NameAffiliation
Sankar D NavaneethanSelzman Institute for Kidney Health, Baylor College of Medicine, Institute of Clinical and Translational Research, Michael E. DeBakey Veterans Affairs Medical Center
Juliana C N ChanHong Kong Institute of Diabetes and Obesity, and Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong
Nikhil TandonAll India Institute of Medical Sciences
Ian H de BoerKidney Research Institute, University of Washington
Ian H de BoerKidney Research Institute, University of Washington
  • 1 - 5

Datasets